Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma

Published:2019-03 Issue:3 Volume:70 Page:449-457
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Yu Su Jong,Ma Chi,Heinrich Bernd^ORCID,Brown Zachary J.^ORCID,Sandhu Milan,Zhang Qianfei,Fu Qiong,Agdashian David,Rosato Umberto,Korangy Firouzeh,Greten Tim F.^ORCID

Publisher

Elsevier BV

Subject

Hepatology

Reference48 articles.

1. Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?;El-Serag;Hepatology,2014

2. Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome;Chen;Eur J Surg Oncol,2004

3. Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression;Serafini;Semin Cancer Biol,2006

4. Circulating CD14+ HLA-DR-/low myeloid-derived suppressor cells predicted early recurrence of hepatocellular carcinoma after surgery;Gao;Hepatol Res,2016

5. The clinical and prognostic significance of CD14(+)HLA-DR(-/low) myeloid-derived suppressor cells in hepatocellular carcinoma patients receiving radiotherapy;Wang;Tumour Biol,2016

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD4 ⁺ T cells with convergent TCR recombination reprogram stroma and halt tumor progression in adoptive therapy;Science Immunology;2024-09-13

2. Gut microbiota-mediated activation of GSDMD ignites colorectal tumorigenesis;Cancer Gene Therapy;2024-06-19

3. The Role of Metabolic Reprogramming in the Tumor Immune Microenvironment: Mechanisms and Opportunities for Immunotherapy in Hepatocellular Carcinoma;International Journal of Molecular Sciences;2024-05-21

4. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives;Journal of Hematology & Oncology;2024-05-08

5. Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives;Journal of Hematology & Oncology;2024-04-29